Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.
Merrill JT, Guthridge J, Smith M, June J, Koumpouras F, Machua W, Askanase A, Khosroshahi A, Sheikh SZ, Rathi G, Burington B, Foster P, Matijevic M, Arora S, Wang X, Gao M, Wax S, James JA, Zack DJ. Merrill JT, et al. Among authors: sheikh sz. Arthritis Rheumatol. 2023 Dec;75(12):2185-2194. doi: 10.1002/art.42652. Arthritis Rheumatol. 2023. PMID: 37459248 Clinical Trial.
Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies.
Williams JN, Dall'Era M, Lim SS, Feldman CH, Arntsen KA, Blazer AD, Goode T, Merrill JT, Sheikh S, Stevens AM, Lipsky PE, Costenbader KH. Williams JN, et al. Arthritis Care Res (Hoboken). 2022 Mar;74(3):420-426. doi: 10.1002/acr.24474. Epub 2022 Jan 19. Arthritis Care Res (Hoboken). 2022. PMID: 33026693 Free PMC article.
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus.
Ginzler E, Guedes Barbosa LS, D'Cruz D, Furie R, Maksimowicz-McKinnon K, Oates J, Santiago MB, Saxena A, Sheikh S, Bass DL, Burriss SW, Gilbride JA, Groark JG, Miller M, Pierce A, Roth DA, Ji B. Ginzler E, et al. Arthritis Rheumatol. 2022 Jan;74(1):112-123. doi: 10.1002/art.41900. Epub 2021 Dec 9. Arthritis Rheumatol. 2022. PMID: 34164944 Free PMC article. Clinical Trial.
Feasibility and Utility of a Pilot Peer Education Program to Improve Patient Engagement in Lupus Clinical Trials: Implementation and Evaluation in a Multisite Model Within a Lupus Clinical Trials Network.
Sheikh SZ, Donovan C, Menezes C, Roy AT, Simkus A, Gross D, Askanase A, Ramsey-Goldman R, Majithia V, Wanty N, McNeill A, Holtz K, Lim SS. Sheikh SZ, et al. ACR Open Rheumatol. 2023 Dec;5(12):701-711. doi: 10.1002/acr2.11612. Epub 2023 Oct 25. ACR Open Rheumatol. 2023. PMID: 37881151 Free PMC article.
A Provider-Based Approach to Address Racial Disparities in Lupus Clinical Trial Participation.
Wanty NI, Cooper DL, Simkus A, Twombly EC, McCalla S, Holtz SKD, Langford AT, Cozart T, Gorlitsky B, Moore C, Culton D, Richardson CT, Wardrop RM, Newcomb J, Aranow C, Lim S, Anandarajah A, Sheikh SZ. Wanty NI, et al. Among authors: sheikh sz. Arthritis Care Res (Hoboken). 2023 Jul;75(7):1434-1442. doi: 10.1002/acr.25054. Epub 2023 Jan 23. Arthritis Care Res (Hoboken). 2023. PMID: 36342382
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial.
Sheikh SZ, Scheinberg MA, Wei JC, Tegzova D, Stohl W, de Toledo RA, Mucenic T, Banfi MRA, Maksimowicz-McKinnon K, Abud-Mendoza C, Navarra S, Garcia M, Garcia-De La Torre I, Ros JO, Levy RA, Bass DL, Terrés JR, Punwaney R, Harris J, Nami A, Pierce A, Thorneloe KS, Ji B, Roth DA. Sheikh SZ, et al. Lancet Rheumatol. 2021 Feb;3(2):e122-e130. doi: 10.1016/S2665-9913(20)30355-6. Epub 2020 Dec 15. Lancet Rheumatol. 2021. PMID: 38279368
71 results